Stock ABLI ABLIVA AB
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Abliva AB

Equities

ABLI

SE0002575340

Delayed Nasdaq Stockholm
Other stock markets
 11:29:42 2024-06-05 am EDT 		5-day change 1st Jan Change
0.1788 SEK -0.89% Intraday chart for Abliva AB -0.22% -27.17%
May. 30 Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug MT
May. 30 Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ABLIVA AB Stock Abliva AB
 23.15M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 109B
BIONTECH SE Stock BioNTech SE
 24.74B -
ARGENX SE Stock argenx SE
 22.67B -
GENMAB A/S Stock Genmab A/S
 18.14B
  1. Stock Market
  2. Equities
  3. ABLI Stock
  4. Charts Abliva AB
  5. Sector Chart